Pages that link to "Q42748357"
Jump to navigation
Jump to search
The following pages link to BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway (Q42748357):
Displaying 50 items.
- The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia (Q26775506) (← links)
- Clinical implications of the molecular genetics of chronic lymphocytic leukemia (Q26830955) (← links)
- The pathogenesis of chronic lymphocytic leukemia (Q27025715) (← links)
- Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo (Q27314650) (← links)
- MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia (Q28241703) (← links)
- Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors (Q33566747) (← links)
- B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation (Q33581388) (← links)
- Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL (Q33714712) (← links)
- A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias (Q33891940) (← links)
- 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition (Q33997214) (← links)
- Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy (Q34020276) (← links)
- Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells (Q34021737) (← links)
- Gene cloning, expression and functional characterization of a proliferation-inducing ligand (APRIL) from hedgehog (Erinaceus europaeus). (Q34128107) (← links)
- B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia (Q34279007) (← links)
- STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cells (Q34419599) (← links)
- The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (Q34542102) (← links)
- Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies (Q34619806) (← links)
- Requirements for innate immune pathways in environmentally induced autoimmunity (Q34655526) (← links)
- CD137 is induced by the CD40 signal on chronic lymphocytic leukemia B cells and transduces the survival signal via NF-κB activation (Q34734190) (← links)
- OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells (Q34876742) (← links)
- TACI expression and signaling in chronic lymphocytic leukemia (Q35534809) (← links)
- Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis. (Q35566828) (← links)
- Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia (Q35791336) (← links)
- Microscale functional cytomics for studying hematologic cancers (Q35849287) (← links)
- TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection (Q35910201) (← links)
- IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival (Q35941404) (← links)
- Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. (Q36016378) (← links)
- Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents (Q36293814) (← links)
- Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia (Q36462375) (← links)
- B-cell maturation antigen is modified by a single N-glycan chain that modulates ligand binding and surface retention (Q36990979) (← links)
- Tailoring of chronic lymphatic leukemia therapy (Q37127542) (← links)
- A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation (Q37201980) (← links)
- Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia (Q37257024) (← links)
- NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia (Q37605861) (← links)
- NF-kappaB as a therapeutic target in chronic lymphocytic leukemia (Q37690750) (← links)
- Inflammation and survival pathways: chronic lymphocytic leukemia as a model system (Q37778876) (← links)
- Chronic Lymphocytic Leukemia: New Concepts for Future Therapy (Q37804595) (← links)
- Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia (Q37971736) (← links)
- Molecular genetics of high-risk chronic lymphocytic leukemia (Q38065304) (← links)
- PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells (Q38780337) (← links)
- Modeling the chronic lymphocytic leukemia microenvironment in vitro (Q38984569) (← links)
- DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies (Q39037081) (← links)
- Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA. (Q39428385) (← links)
- A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells (Q39537457) (← links)
- Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation andDe novoGene Transcription (Q39663702) (← links)
- Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic [corrected] leukemic cells of B-CLL patients. (Q39676539) (← links)
- Reduced APRIL expression induces cellular senescence via a HSPG-dependent pathway (Q39847568) (← links)
- New targets of PS-341: BAFF and APRIL. (Q39849716) (← links)
- Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation (Q39858777) (← links)
- Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. (Q40178334) (← links)